Literature DB >> 10637552

Immunobiology of vasoactive intestinal peptide (VIP)

D Pozo1, M Delgado, M Martínez, J M Guerrero, J Leceta, R P Gomariz, J R Calvo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10637552     DOI： 10.1016/s0167-5699(99)01525-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  22 in total

Review 1.  Horizons in Sjögren's syndrome genetics.

Authors:  Pamela H Williams; Beth L Cobb; Bahram Namjou; R Hal Scofield; Amr H Sawalha; John B Harley
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

Review 3.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

Review 4.  Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

5.  Effect of intracanal medicaments on matrix metalloproteinase-9 and vasoactive intestinal peptide secretion in periapical lesions of re-treated canals: a randomized controlled clinical study.

Authors:  Mine Büker Özdemir; Ertuğrul Karataş; Mevlüt Albayrak; Yasin Bayır
Journal:  Clin Oral Investig       Date:  2018-06-15       Impact factor: 3.573

6.  Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.

Authors:  Emilie E Vomhof-DeKrey; Ashley R Sandy; Jarrett J Failing; Rebecca J Hermann; Scott A Hoselton; Jane M Schuh; Abby J Weldon; Kimberly J Payne; Glenn P Dorsam
Journal:  Peptides       Date:  2011-08-22       Impact factor: 3.750

7.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Authors:  Carmen Martinez; Catalina Abad; Mario Delgado; Alicia Arranz; Maria G Juarranz; Nieves Rodriguez-Henche; Philippe Brabet; Javier Leceta; Rosa P Gomariz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

8.  Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.

Authors:  R Newman; N Cuan; T Hampartzoumian; S J Connor; A R Lloyd; M C Grimm
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 9.  VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.

Authors:  Thomas W Carion; David Kracht; Eliisa Strand; Edwin David; Cody McWhirter; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-12-04       Impact factor: 3.072

10.  The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.

Authors:  Dorit Avni; Amir Philosoph; Michael M Meijler; Tsaffrir Zor
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.